Annual CFF
$231.56 M
NaN%
December 31, 2021
Summary
- As of February 9, 2025, BIOT annual cash flow from financing activities is $231.56 million
Performance
BIOT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$155.00 K
+$117.50 K+313.33%
September 30, 2022
Summary
- As of February 9, 2025, BIOT quarterly cash flow from financing activities is $155.00 thousand, with the most recent change of +$117.50 thousand (+313.33%) on September 30, 2022.
- Over the past year, BIOT quarterly CFF has increased by +$154.10 thousand (+17122.22%).
Performance
BIOT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$307.50 K
+$154.10 K+100.46%
September 30, 2022
Summary
- As of February 9, 2025, BIOT TTM cash flow from financing activities is $307.50 thousand, with the most recent change of +$154.10 thousand (+100.46%) on September 30, 2022.
- Over the past year, BIOT TTM CFF has dropped by -$231.25 million (-99.87%).
Performance
BIOT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BIOT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +10000.0% | -99.9% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
BIOT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -100.0% | -99.9% | -57.6% |
| 5 y | 5-year | at high | at low | -99.9% | -100.0% | -99.9% | -57.6% |
| alltime | all time | at high | at low | -99.9% | -100.0% | -99.9% | -57.6% |
Biotech Acquisition Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $155.00 K(+313.3%) | $307.50 K(+100.5%) |
| Jun 2022 | - | $37.50 K(-67.4%) | $153.40 K(+17.6%) |
| Mar 2022 | - | $115.00 K(>+9900.0%) | $130.40 K(-99.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $231.56 M | $0.00(-100.0%) | $231.56 M(0.0%) |
| Sep 2021 | - | $900.00(-93.8%) | $231.56 M(+0.0%) |
| Jun 2021 | - | $14.50 K(-100.0%) | $231.56 M(+0.0%) |
| Mar 2021 | - | $231.54 M | $231.54 M |
FAQ
- What is Biotech Acquisition annual cash flow from financing activities?
- What is the all time high annual CFF for Biotech Acquisition?
- What is Biotech Acquisition quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Biotech Acquisition?
- What is Biotech Acquisition quarterly CFF year-on-year change?
- What is Biotech Acquisition TTM cash flow from financing activities?
- What is the all time high TTM CFF for Biotech Acquisition?
- What is Biotech Acquisition TTM CFF year-on-year change?
What is Biotech Acquisition annual cash flow from financing activities?
The current annual CFF of BIOT is $231.56 M
What is the all time high annual CFF for Biotech Acquisition?
Biotech Acquisition all-time high annual cash flow from financing activities is $231.56 M
What is Biotech Acquisition quarterly cash flow from financing activities?
The current quarterly CFF of BIOT is $155.00 K
What is the all time high quarterly CFF for Biotech Acquisition?
Biotech Acquisition all-time high quarterly cash flow from financing activities is $231.54 M
What is Biotech Acquisition quarterly CFF year-on-year change?
Over the past year, BIOT quarterly cash flow from financing activities has changed by +$154.10 K (+17122.22%)
What is Biotech Acquisition TTM cash flow from financing activities?
The current TTM CFF of BIOT is $307.50 K
What is the all time high TTM CFF for Biotech Acquisition?
Biotech Acquisition all-time high TTM cash flow from financing activities is $231.56 M
What is Biotech Acquisition TTM CFF year-on-year change?
Over the past year, BIOT TTM cash flow from financing activities has changed by -$231.25 M (-99.87%)